Search
for
Sort by
Research 451–480 of 784
- Resident macrophages of the lung and liver: The guardians of our tissues
- Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
- Revolutionizing Radiotoxicity Management with Mesenchymal Stem Cells and Their Derivatives: A Focus on Radiation-Induced Cystitis
- DNA Damage, Checkpoint Responses, and Cell Cycle Control in Aging Stem Cells
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Cutaneous manifestations associated with immune checkpoint inhibitors
- [Translated article] Characteristics, Management, and Prognostic Implications of Adverse Effects of Immune Checkpoint Inhibitors: A Systematic Review
- Immune checkpoint inhibitor‐related alopecia: Insight into the pathophysiology utilizing non‐invasive diagnostic techniques
- Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- Transposon control as a checkpoint for tissue regeneration
- IMMUNOTHERAPY OF CANCER: IMMUNE CHECKPOINT BLOCKERS, VACCINES AND ADOPTIVE T CELL THERAPIES
- 415 IL-17C: Checkpoint in innate skin immunology
- Hair Graying as an Evolutionary Checkpoint against Malignancy: a Stem Cell Perspective
- 806 Immune related gene expression analysis of de novo primary skin cancers in patients receiving immune checkpoint inhibitors for advanced cSCC
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review
- Wnt is back in drugmakers' sights, but is it druggable?
- Revisión sistemática de los efectos adversos cutáneos causados por fármacos inhibidores de los puntos de control inmunitario: características, manejo y pronóstico
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors
- Eyelash trichomegaly complicating pembrolizumab for colorectal cancer
- Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy
- Cutaneous lupus erythematosus induced by tislelizumab
- Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
- Alopecia Areata in a Patient Receiving Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma